source
- UK regulator MHRA unveils multi-year plan to speed AI-driven drug oversightThe UK Medicines and Healthcare products Regulatory Agency (MHRA) has released a multi-year strategy aimed at keeping its regulatory framework patient-focused as artificial intelligence and persona…
- European biotech CEOs divided on whether US or China will lead future partnership deals, Europe seen as laggingA BIO-Europe survey of 81 leaders from privately‑owned European biotech companies found the group split on which region will dominate future innovation partnerships. Twenty‑nine respondents said th…